Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

Researchers found metformin, a common diabetes drug, may protect against blood cancer AML by targeting pre-cancerous cells.

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

A widely used diabetes drug holds promise in the treatment of the third biggest cancer killer in the UK, new research ...

Research from the University of Cambridge shows that metformin, a widely used and affordable diabetes drug, could prevent a ...

Delhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain ...

Delirium is a sudden and serious condition that causes confusion and a lack of awareness. It often happens quickly, ...

Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are ...

At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease, a study ...